FONR (FONR)
Diagnostics & Research
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
—
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for FONR yet.
Peers in Diagnostics & Research
All in industry →TMO#1
Thermo Fisher Scientific Inc.
$185.98B-0.60%
DHR#2
Danaher Corporation
$136.58B-1.63%
IDXX#3
IDEXX Laboratories, Inc.
$46.56B-1.20%
A#4
Agilent Technologies, Inc.
$32.61B-1.31%
WAT#5
Waters Corporation
$31.16B-0.28%
NTRA#6
Natera, Inc.
$28.77B-3.71%
IQV#7
IQVIA Holdings Inc.
$28.37B-2.06%
MTD#8
Mettler-Toledo International Inc.
$27.03B+0.93%
LH#9
Labcorp Holdings Inc.
$22.52B-0.53%
DGX#10
Quest Diagnostics Incorporated
$21.90B-0.50%
Recent press releases
FONR has not issued a press release in this window.
SEC filings
All filings →FONR has not filed an SEC document in this window.
Insider trades
All insider trades →FONR has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
251,350 sh-53.2%
510,672 sh+5.6%
RBF Capital, LLC$2.8M
150,894 sh+106.5%
373,317 sh-1.0%
315,716 sh+2.3%
VANGUARD GROUP INC$6.8M
363,788 sh-6.3%
MARSHALL WACE, LLP$523,040
28,181 sh● NEW
Royal Bank of Canada$2,000
132 sh-99.6%
People at FONR
All people →No officers or directors have been indexed for FONR.
Quarterly financials
Full financials →Revenue trend
12/24
$23.1M
NI $2.0M
03/25
$27.2M
NI $2.5M
09/25
$26.0M
NI $2.3M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.10
Prior: $0.37
Revenue sparkline